Estonia, July 14 -- Estonia based TAMRO EESTI OU has secured contract from Tervisekassa for Pharmaceutical Products-Bevatsizumabi, NAB-Paclitzel and Totsilizumab Purchase 2025. The value of the contract is worth 62738550 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....